Results 141 to 150 of about 56,186 (320)

Pharmacokinetics of finrozole (MPV‐2213ad), a novel selective aromatase inhibitor, in healthy men [PDF]

, 2001
Outi Ahokoski, Kerttu Irjala, Mikko Taalikka, Pekka Manninen, Kaija Halonen, Lauri Kangas, Eeva Salminen, Risto Huupponen, Harry Scheinin   +8 more
openalex   +1 more source

A Telehealth-Delivered Tai Chi Intervention (TaiChi4Joint) for Managing Aromatase Inhibitor–Induced Arthralgia in Patients With Breast Cancer During COVID-19: Longitudinal Pilot Study [PDF]

, 2022
Sameh Gomaa, Carly West, Ana Mariá López, Tingting Zhan, Max Schnoll, Maysa Abu‐Khalaf, Andrew B. Newberg, Kuang‐Yi Wen   +7 more
openalex   +1 more source

Mapping molluscan endocrinology: a systematic and critical appraisal

Biological Reviews, Volume 101, Issue 2, Page 970-1002, April 2026.
ABSTRACT Historically, a vertebrate‐centric paradigm has framed our interpretation of molluscan endocrinology, with considerable research focusing on vertebrate‐type steroid hormones (e.g. oestrogens, testosterone). However, contradictory evidence on the occurrence of vertebrate‐type steroid hormones in molluscan tissues, and a lack of the specific ...
Konstantinos Panagiotidis, Thomas H. Miller, Olwenn V. Martin, Alice Baynes   +3 more
wiley   +1 more source

Optimizing the integration of modern systemic therapies and advanced radiotherapy techniques in breast cancer management: An expert opinion from the Institut Curie Breast Radiotherapy Group

International Journal of Cancer, Volume 158, Issue 7, Page 1775-1784, 1 April 2026.
Abstract The integration of modern systemic therapies with radiotherapy (RT) represents a promising strategy in breast cancer management, enhancing both locoregional control and systemic disease outcomes. This expert consensus from the Institut Curie Breast Radiotherapy Group focuses exclusively on modern systemic agents, synthesizing current evidence ...
Cezara Cheptea, Pierre Loap, Sofiane Allali, Alain Fourquet, Kim Cao, Youlia Kirova   +5 more
wiley   +1 more source

Additional file 2: of The lncRNA MIR2052HG regulates ERÎą levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

, 2019
Junmei Cairns, James N. Ingle, Krishna R. Kalari, Lois E. Shepherd, Michiaki Kubo, Matthew P. Goetz, Richard M. Weinshilboum, Liewei Wang   +7 more
openalex   +1 more source

Reprogramming SREBP1‐dependent lipogenesis and inflammation in high‐risk breast with licochalcone A: A novel path to cancer prevention

International Journal of Cancer, Volume 158, Issue 7, Page 1927-1940, 1 April 2026.
What's new? Endocrine drugs repurposed from treatment protocols are the primary medications available for breast cancer (BC) prevention in at‐risk women. Adverse effects, however, significantly minimize uptake and prevention impact. Here, the authors investigated licochalcone A (LicA), a non‐endocrine anti‐inflammatory agent with reported hematologic ...
Atieh Hajirahimkhan, Elizabeth T. Bartom, Carolina H. Chung, Xingyu Guo, Kyli Berkley, Seyyedmohsen Hosseinibarkooie, Zahra Assadi, Shao Huan Samuel Weng, Raymond Moellering, Oukseub Lee, Ruohui Chen, Wonhwa Cho, Sriram Chandrasekaran, Susan E. Clare, Seema A. Khan   +14 more
wiley   +1 more source

A Case for the Use of Combined Hormonal Therapy for Aggressive Angiomyxoma: Complete Response to Goserelin and Letrozole Following Incomplete Surgical Resection

Clinical Case Reports
We report on the use of combined hormonal therapy with a gonadotropin releasing hormone antagonist and aromatase inhibitor in pelvic aggressive angiomyxoma, with a complete response.
George Mallat, Annabelle Farnsworth, Florian Honeyball, Michael Solomon, Peter Grimison   +4 more
doaj   +1 more source

Laser and radiofrequency for treating genitourinary syndrome of menopause in breast cancer survivors: A systematic review of randomized controlled trial

International Journal of Gynecology &Obstetrics, Volume 173, Issue 1, Page 99-108, April 2026.
Abstract Background Breast cancer survivors (BCS) often experience more severe symptoms of genitourinary syndrome of menopause (GSM). As estrogen‐based hormonal therapy is generally avoided in BCS, physical energy methods may offer promising non‐hormonal alternatives.
Nicoli Serquiz, Ayane Cristine Alves Sarmento, Antonio Carlos Queiroz de Aquino, Natalie Rios Almeida, Maria Luísa Nobre, Juliana Dantas de Araújo Santos Camargo, Kleyton Santos de Medeiros, Ana Katherine Gonçalves   +7 more
wiley   +1 more source

Investigation of aromatase inhibitory activity of metal complexes of 8-hydroxyquinoline and uracil derivatives

Drug Design, Development and Therapy, 2014
Veda Prachayasittikul,1 Ratchanok Pingaew,2 Chanin Nantasenamat,3 Supaluk Prachayasittikul,3 Somsak Ruchirawat,4,5 Virapong Prachayasittikul1 1Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University ...
Prachayasittikul V, Pingaew R, Nantasenamat C, Prachayasittikul S, Ruchirawat S, Prachayasittikul V   +5 more
doaj  

Aromatase Inhibitors: New Drug of Choice for Induction of Ovulation

, 1970
Maruf Siddiqui, Nusrat Mahmud, MR Begum, TA Chowdhury   +3 more
openalex   +2 more sources